Elanco Animal Health Inc ELAN

About Elanco Animal Health Inc (ELAN): stock profile, AI score and financials

Elanco Animal Health Inc (ELAN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ELAN at 49.0/100 on a composite quality score built from its SEC filings, placing it at rank #1,703 of 2,925 stocks — the bottom half of the AI-ranked universe. ELAN scores in the top quartile across earnings quality (91.2), revenue scale (77.7). Areas of concern include profitability (22.3) and balance sheet strength (29.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Elanco Animal Health Inc reports quarterly revenue of $1.4B, net income of $54.0M, an operating margin of 4.1%. Top institutional holders of ELAN by reported 13-F value include DODGE & COX, FMR, BlackRock, based on the most recent SEC filings. ELAN trades on the NYSE exchange and files with the SEC under CIK 1739104. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ELAN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Elanco Animal Health Inc directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1739104 →